Stewart McCallum, Chief Medical Officer at Recro Pharma, Inc. (REPH), bought 1,250 shares at $8.15 ($10K) on 2016-05-26, disclosed to the SEC on 2016-05-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.15 | 1,000 | $8K | 79.3% |
| 2 | $8.50 | 250 | $2K | 20.7% |
| Total | $8.22 avg | 1,250 | $10K | 100% |